Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2014
06/26/2014WO2014098945A1 Dry powder inhaler and methods of use
06/26/2014WO2014098932A1 Treatment of mtor hyperactive related diseases and disorders
06/26/2014WO2014098926A1 Pharmaceutical compounds
06/26/2014WO2014098887A1 Levothyroxine formulation with acacia
06/26/2014WO2014098886A1 Levothyroxine formulation with carrageenan
06/26/2014WO2014098877A1 Substituted noribogaine
06/26/2014WO2014098870A1 Oral care composition
06/26/2014WO2014098869A1 Oral care composition containing ionic liquids
06/26/2014WO2014098868A1 Oral care composition containing ionic liquids
06/26/2014WO2014098867A1 Oral care composition containing ionic liquids
06/26/2014WO2014098823A1 Animal food composition and method
06/26/2014WO2014098759A1 Germicidal compositions comprising carboxylic acid mixture and use as topical disinfectants
06/26/2014WO2014098649A1 Compositions and methods using toll-like receptor 5 and toll-like receptor agonist
06/26/2014WO2014098624A1 Veterinary injectable formulations
06/26/2014WO2014098623A1 Injectable eprinomectin formulation and anthelmintic use thereof
06/26/2014WO2014098619A1 Transdermal parasiticidal formulations
06/26/2014WO2014098597A1 Novel bis-chromone derivatives, methods for their preparation and uses thereof
06/26/2014WO2014098593A1 Verapamil like compounds
06/26/2014WO2014098552A1 Pharmaceutical composition comprising a combination of a non-steroidal anti-inflammatory agent, an adjuvant agent and an antineuritic analgesic, having an antinociceptive effect
06/26/2014WO2014098516A1 Composition comprising pegylated betulin derivatives, for preventing or treating diaper dermatitis
06/26/2014WO2014098512A1 Pharmaceutical composition comprising fucosterol, as active ingredient, for preventing or treating neurodegenerative diseases
06/26/2014WO2014098464A1 Human serum albumin heat-stabilizing composition, and production method for heat-stabilized human serum albumin using same
06/26/2014WO2014098307A1 Anticancer pharmaceutical composition
06/26/2014WO2014098306A1 Pharmaceutical composition for preventing or treating dementia
06/26/2014WO2014098249A1 Composition having tissue repairing activity and utilization thereof
06/26/2014WO2014098232A1 Pharmaceutical composition comprising pi3 kinase inhibitor, pharmaceutical composition comprising compound which acts on vitamin d receptor, freeze-dried composition, method for producing freeze-dried composition, and pharmaceutical composition for transpulmonary administration
06/26/2014WO2014098210A1 Apoptosis-inducing agent
06/26/2014WO2014098190A1 Composition and food or drink
06/26/2014WO2014098176A1 Amorphous form of quinoline derivative, and method for producing same
06/26/2014WO2014098098A1 Heterocyclic amide derivative, and medicine containing same
06/26/2014WO2014098092A1 Prophylactic/therapeutic agent for dry eye
06/26/2014WO2014098088A1 Antifungal agent
06/26/2014WO2014098054A1 Antiviral agent
06/26/2014WO2014098015A1 1-aryl-1-heterodiene compound and pesticide
06/26/2014WO2014097875A1 Development of pluripotent stem cell employing novel dedifferentiation induction method
06/26/2014WO2014097721A1 Ascorbic acid derivative composition and method for producing same, ascorbic acid derivative solution, and external preparation for skin
06/26/2014WO2014097318A2 Agents for eliminating tumour-initiating cells
06/26/2014WO2014097209A1 A pharmaceutical composition containing candesartan cilexetil and amlodipine
06/26/2014WO2014097188A1 Compounds of 2,3-dihydro-4h-1,3-benzoxazine-4-one, method for preparing them and pharmaceutical form comprising them
06/26/2014WO2014097148A1 Tricyclic compounds for inhibiting the cftr channel
06/26/2014WO2014097147A1 Tricyclic compounds as cftr inhibitors
06/26/2014WO2014097140A1 Indole carboxamide derivatives as p2x7 receptor antagonists
06/26/2014WO2014097125A1 Pharmaceutical combination comprising binimetinib
06/26/2014WO2014097038A1 CARBOCYCLIC- AND HETEROCYCLIC-SUBSTITUTED HEXAHYDROPYRANO[3,4-d][1,3]THIAZIN-2-AMINE COMPOUNDS
06/26/2014WO2014096984A1 Stable pharmaceutical composition of sodium oxybate
06/26/2014WO2014096983A1 Stable pharmaceutical compositions of saxagliptin or salts thereof
06/26/2014WO2014096982A1 Stable pharmaceutical compositions of saxagliptin or salts thereof
06/26/2014WO2014096958A1 Inosine monophosphate and salts thereof for use in the treatment of complement-related disorders
06/26/2014WO2014096941A1 Cyclic sulfonamides as sodium channel blockers
06/26/2014WO2014096864A1 Enzyme inhibitors
06/26/2014WO2014096828A1 Pharmaceutical formulation of n- [5- [2-(3,5-dimethoxyphenyl) ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl] benzamide
06/26/2014WO2014096757A1 Pyridazinones as daao enzyme inhibitors
06/26/2014WO2014096740A1 Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum
06/26/2014WO2014096697A1 Use of acetylsalicylic acid to prevent and/or treat diabetic wounds
06/26/2014WO2014096497A1 Liquid carbocisteine formulations having improved properties
06/26/2014WO2014096485A1 Oral pharmaceutical composition for drugs with a high-dosage regimen
06/26/2014WO2014096464A1 Pharmaceutical composition comprising leflunomide
06/26/2014WO2014096454A1 Soluble, dispersible or orodispersible tablets comprising cyclophosphamide
06/26/2014WO2014096425A2 Prodrugs of monomethyl fumarate (mmf)
06/26/2014WO2014096423A1 Therapeutically active pyrazolo-pyrimidine derivatives
06/26/2014WO2014096418A2 Micrornas as therapeutics and biomarkers for epilepsy
06/26/2014WO2014096387A1 Solid unit with high fexofenadine content and process for the preparation thereof
06/26/2014WO2014096378A1 Saturated nitrogen and n-acylated heterocycles potentiating the activity of an active antibiotic against mycobacteria
06/26/2014WO2014096373A1 Process for prepararing n-(2-(7-methoxy-1-naphthalenyl)ethyl) acetamide and solid forms thereof
06/26/2014WO2014096365A1 Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
06/26/2014WO2014096343A1 Novel forms of telaprevir
06/26/2014WO2014096301A1 ß2-ADRENOCEPTOR AGONIST FOR IMPROVEMENT OF EXERCISE TOLERANCE
06/26/2014WO2014096300A2 Antibacterial compounds
06/26/2014WO2014096277A1 Tablet composition comprising cinacalcet hydrochloride
06/26/2014WO2014096257A1 Freeze-dried cross-linked hyaluronic acid sponge
06/26/2014WO2014096212A1 NOVEL TRICYCLIC 3,4-DIHYDRO-2H-PYRIDO[1,2-α]PYRAZINE-1,6-DIONE DERIVATIVES AS GAMMA SECRETASE MODULATORS
06/26/2014WO2014096209A1 A pharmaceutical formulation comprising inositol and selenium, preparation and use thereof
06/26/2014WO2014096193A1 Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemia
06/26/2014WO2014096191A1 Bis 2h-imidazole-2-thione chelating agents as ligands for radiopharmaceutical in vivo imaging
06/26/2014WO2014096176A1 Novel crystalline forms of ceftaroline fosamil
06/26/2014WO2014096155A1 Glutamate derivatives for topical use as immunomodulatory active ingredient
06/26/2014WO2014096133A1 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the treatment of atherosclerosis
06/26/2014WO2014096124A1 Film coated pellets
06/26/2014WO2014096116A1 Pharmaceutical formulation comprising ciclesonide
06/26/2014WO2014096115A1 Ciclesonide for the treatment of airway disease in horses
06/26/2014WO2014096093A1 3,5-diarylazaindoles as dyrk1a protein inhibitors for the treatment of cognitive deficiences associated with down's syndrome and with alzheimer's disease
06/26/2014WO2014096068A1 Oral care product comprising lactylate
06/26/2014WO2014095953A1 Dialysis composition
06/26/2014WO2014095929A1 Composition and kit comprising piperazine derivatives and metformin, and use thereof in the treatment of diabetes
06/26/2014WO2014095924A1 Combination of umeclidinium, fluticasone propionate and salmeterol xinafoate for use in the treatment of inflammatory or respiratory tract diseases
06/26/2014WO2014095920A1 New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activity
06/26/2014WO2014095845A1 Tablets with improved acceptance and good storage stability
06/26/2014WO2014095833A1 Combination comprising radium-223 for the treatment of cancer
06/26/2014WO2014095822A1 An improved process for making zilpaterol
06/26/2014WO2014095818A1 Formulation comprising amorphous agomelatine
06/26/2014WO2014095798A1 Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders (gpr84 antagonists)
06/26/2014WO2014095775A1 Bet-protein-inhibiting dihydroquinoxalinones
06/26/2014WO2014095774A1 Bet-protein-inhibiting dihydropyridopyrazinones
06/26/2014WO2014095757A1 Methods and pharmaceutical compositions for the treatment of x-linked charcot-marie-tooth
06/26/2014WO2014095700A1 Novel compounds
06/26/2014WO2014095663A1 New use of aclidinium
06/26/2014WO2014095628A1 Oral formulation containing a statin in omega-3 polyunsaturated fatty acids (n-3 pufa)
06/26/2014WO2014095625A1 Anti-dandruff composition
06/26/2014WO2014095602A1 Combination of levocabastine and fluticasone furoate for the treatment of inflammatory and/or allergic conditions
06/26/2014WO2014095489A1 Topical oral composition for alleviating dry mouth symptoms and for treating mouth ulcers
1 ... 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 ... 7860